Log in with your email address username.

×

Attention doctorportal newsletter subscribers,

After December 2018, we will be moving elements from the doctorportal newsletter to MJA InSight newsletter and rebranding it to Insight+. If you’d like to continue to receive a newsletter covering the latest on research and perspectives in the medical industry, please subscribe to the Insight+ newsletter here.

As of January 2019, we will no longer be sending out the doctorportal email newsletter. The final issue of this newsletter will be distributed on 13 December 2018. Articles from this issue will be available to view online until 31 December 2018.

Arrhythmia management distilled

The authors of this book work in Australia, the United Kingdom and Canada, and are well known to and respected by many Australian cardiologists working in the field of cardiac arrhythmia. The first edition was published in 2010. In view of the rapid advances in arrhythmia management, particularly the new medication and guidelines for management of atrial fibrillation (AF), as well as in catheter ablation, the authors considered a second edition warranted.

The target audience includes general practitioners, nurses, medical students, technicians and cardiology trainees. The layout is as simple as possible for a very complex subject. As is to be expected, because of its prevalence, AF is given prominence. The use of two important guidelines for assessing risk of thromboembolism and bleeding in patients with AF is emphasised: the CHA2DS2-VASc (congestive heart failure, hypertension, age >75 years [doubled], diabetes mellitus, stroke [doubled], vascular disease, age 65–74 years, sex category) score; and the HAS-BLED (hypertension, abnormal renal/liver function, stroke, bleeding history or predisposition, labile international normalised ratio, elderly, drugs/alcohol concomitantly) score.

Some antiarrhythmic drugs mentioned are unavailable in Australia,…

email